| 000 | 01710 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250517114112.0 | ||
| 264 | 0 | _c20170529 | |
| 008 | 201705s 0 0 spa d | ||
| 022 | _a1578-1879 | ||
| 024 | 7 |
_a10.1016/j.arteri.2016.06.001 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBrea, Angel | |
| 245 | 0 | 0 |
_a[Fibrates therapy: Rational use fenofibrate 2016. Executive summary]. _h[electronic resource] |
| 260 |
_bClinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis _c |
||
| 300 |
_a295-301 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aCardiovascular Diseases _xetiology |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aDyslipidemias _xcomplications |
| 650 | 0 | 4 |
_aFenofibrate _xadministration & dosage |
| 650 | 0 | 4 |
_aFibric Acids _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aHypolipidemic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aLipids _xblood |
| 650 | 0 | 4 |
_aMetabolic Diseases _xcomplications |
| 650 | 0 | 4 | _aRisk Factors |
| 700 | 1 | _aMillán, Jesús | |
| 700 | 1 | _aAscaso, Juan F | |
| 700 | 1 | _aBlasco, Mariano | |
| 700 | 1 | _aDíaz, Angel | |
| 700 | 1 | _aGonzález-Santos, Pedro | |
| 700 | 1 | _aHernández-Mijares, Antonio | |
| 700 | 1 | _aMantilla, Teresa | |
| 700 | 1 | _aPedro-Botet, Juan C | |
| 700 | 1 | _aPintó, Xavier | |
| 773 | 0 |
_tClinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis _gvol. 28 _gno. 6 _gp. 295-301 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.arteri.2016.06.001 _zAvailable from publisher's website |
| 999 |
_c26402625 _d26402625 |
||